The expansion of targetable biomarkers for CAR T cell therapy

Biomarkers are an integral part of cancer management due to their use in risk assessment, screening, differential diagnosis, prognosis, prediction of response to treatment, and monitoring progress of disease. Recently, with the advent of Chimeric Antigen Receptor (CAR) T cell therapy, a new category...

Descripción completa

Detalles Bibliográficos
Autores principales: Townsend, Michelle H., Shrestha, Gajendra, Robison, Richard A., O’Neill, Kim L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054736/
https://www.ncbi.nlm.nih.gov/pubmed/30031396
http://dx.doi.org/10.1186/s13046-018-0817-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054736/
https://www.ncbi.nlm.nih.gov/pubmed/30031396
http://dx.doi.org/10.1186/s13046-018-0817-0

Ejemplares similares